{"id":"W4399566448","doi":"10.1182/bloodadvances.2024012693","title":"Cumulative incidence estimates for solid tumors after HCT in the CIBMTR and California Cancer Registry","year":2024,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"National Institute of Allergy and Infectious Diseases; Office of Naval Research; National Center for Chronic Disease Prevention and Health Promotion; National Heart, Lung, and Blood Institute; Legend Biotech; Pharmacyclics; Takeda Oncology; Health Resources and Services Administration; Seagen; Kiadis Pharma; bluebird bio; Medac; Jazz Pharmaceuticals; BeiGene; National Center for Advancing Translational Sciences; HistoGenetics; Swedish Orphan Biovitrum; Omeros Corporation; Vertex Pharmaceuticals; Alexion Pharmaceuticals; Mallinckrodt Pharmaceuticals; Astellas Pharma US; University of Southern California; Atara Biotherapeutics; CareDx; Actinium Pharmaceuticals; National Cancer Institute; Gilead Sciences; Astellas Pharma; Adaptive Biotechnologies; MorphoSys; California Department of Public Health; Sanofi; GlaxoSmithKline; CSL Behring; Bristol-Myers Squibb; AstraZeneca; Centers for Disease Control and Prevention; Gateway for Cancer Research; Amgen; Incyte; Pfizer","keywords":"Cumulative incidence; Population; Medicine; Incidence (geometry); Cohort; Cancer registry; Transplantation; Hematopoietic cell; Oncology; Demography; Internal medicine; Environmental health; Biology; Mathematics; Haematopoiesis","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003832254,0.000277486,0.0003367948,0.003513449,0.0002975678,0.00103632,0.0008155482,0.0002656879,0.002285097],"category_scores_gemma":[0.01027062,0.0003411608,0.0008415378,0.003614651,0.0001899413,0.0005543596,0.0007199864,0.0007711514,0.000369121],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001634783,"about_ca_system_score_gemma":0.002141112,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.1310158,"about_ca_topic_score_gemma":0.0841535,"domain_scores_codex":[0.9976928,0.0004767344,0.0003350209,0.0006509984,0.0006857411,0.0001586567],"domain_scores_gemma":[0.9869751,0.002684918,0.005453898,0.001295783,0.003135175,0.0004551403],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00006734209,0.0000221808,0.9849147,0.0001089162,0.0004155649,0.00002588254,0.00008040087,0.003078038,0.00005249637,0.0004247594,0.005964183,0.004845548],"study_design_scores_gemma":[0.00003329423,0.00004857546,0.9874999,0.0001054606,0.000271468,0.0001394138,0.0002011036,0.004891197,0.0001514316,0.000197989,0.006438015,0.00002220751],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8208205,0.003504134,0.008681356,0.0008192675,0.00008433917,0.0002780451,0.1555564,0.0003893417,0.009866631],"genre_scores_gemma":[0.9039527,0.001367537,0.003080152,0.0001444048,0.00005550998,0.0002002934,0.08996036,0.00003561411,0.001203421],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1310158,"threshold_uncertainty_score":0.2605064,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01571897578083386,"score_gpt":0.356687035706387,"score_spread":0.3409680599255532,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}